EIA
ATRC icon

Emerald Investment Advisers’s AtriCure ATRC Stock Holding History

Emerald Investment Advisers’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Buy
79,102
+7,610
+11% +$214K 0.15% 177
2026
Q1 		$2.04M Buy
+71,492
New +$2.44M 0.18% 155

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Emerald Investment Advisers's ATRC Position: Q2 2026 in Review

Emerald Investment Advisers increased its AtriCure (ATRC) stake by 11% in Q2 2026, buying an estimated $214K and bringing the position to 79,102 shares worth $2.21M. The position accounts for 0.15% of the portfolio, ranked #177.

Emerald Investment Advisers first reported a position in ATRC in Q1 2026 and has held it in 2 quarters since. 250 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Emerald Investment Advisers held 79,102 shares of AtriCure worth $2.21M as of Q2 2026.
  • Emerald Investment Advisers bought 7,610 AtriCure shares in Q2 2026, an estimated $214K.
  • AtriCure made up 0.15% of Emerald Investment Advisers's portfolio in Q2 2026, its #177 holding.
  • Emerald Investment Advisers first reported a position in AtriCure in Q1 2026 and has held it in 2 quarters since.
  • 250 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Emerald Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.